Skip to main content

Bristol-Myers Squibb: Strong Quality And Attractive Valuation

Bristol-Myers Squibb has an outstanding track record of consistent revenue growth and superior profitability. The stock is very reasonably valued at current levels.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.